Literature DB >> 7582456

Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).

D Häfner1, R Beume, U Kilian, G Krasznai, B Lachmann.   

Abstract

1. We have examined the effects of five different lung surfactant factor (LSF) preparations in the rat lung lavage model. In this model repetitive lung lavage leads to lung injury with some similarities to adult respiratory distress syndrome with poor gas exchange and protein leakage into the alveolar spaces. These pathological sequelae can be reversed by LSF instillation soon after lavage. 2. The tested LSF preparations were: two bovine: Survanta and Alveofact: two synthetic: Exosurf and a protein-free phospholipid based LSF (PL-LSF) and one Recombinant LSF at doses of 25, 50 and 100 mg kg-1 body weight and an untreated control group. 3. Tracheotomized rats (10-12 per dose) were pressure-controlled ventilated (Siemens Servo Ventilator 900C) with 100% oxygen at a respiratory rate of 30 breaths min-1, inspiration expiration ratio of 1:2, peak inspiratory pressure (PIP) of 28 cmH2O at positive end-expiratory pressure (PEEP) of 8 cmH2O. Two hours after LSF administration, PEEP and in parallel PIP was reduced from 8 to 6 (1st reduction), from 6 to 3 (2nd reduction) and from 3 to 0 cmH2O (3rd reduction). 4. Partial arterial oxygen pressure (PaO2, mmHg) at 5 min and 120 min after LSF administration and during the 2nd PEEP reduction (PaO2(PEEP23/3)) were used for statistical comparison. All LSF preparations caused a dose-dependent increase for the PaO2(120'), whereas during the 2nd PEEP reduction only bovine and recombinant LSF exhibited dose-dependency. Exosurf did not increase PaO2 after administration of the highest dose. At the highest dose Exosurf exerted no further improvement but rather a tendency to relapse. The bovine and the Recombinant LSF are superior to both synthetic LSFpreparations.5. In this animal model and under the described specific ventilatory settings, even between bovine LSFpreparations there are detectable differences that are pronounced when compared to synthetic LSFwithout any surfactant proteins. We conclude that the difference between bovine and synthetic LSFpreparations can be overcome by addition of the surfactant protein C.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582456      PMCID: PMC1908419          DOI: 10.1111/j.1476-5381.1995.tb16354.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

Review 1.  Surfactant replacement in adult respiratory distress syndrome.

Authors:  G Enhorning
Journal:  Am Rev Respir Dis       Date:  1989-08

2.  Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage.

Authors:  P Berggren; B Lachmann; T Curstedt; G Grossmann; B Robertson
Journal:  Acta Anaesthesiol Scand       Date:  1986-05       Impact factor: 2.105

3.  The incidence of the adult respiratory distress syndrome.

Authors:  J Villar; A S Slutsky
Journal:  Am Rev Respir Dis       Date:  1989-09

4.  High-dose corticosteroids in patients with the adult respiratory distress syndrome.

Authors:  G R Bernard; J M Luce; C L Sprung; J E Rinaldo; R M Tate; W J Sibbald; K Kariman; S Higgins; R Bradley; C A Metz
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

Review 5.  The adult respiratory distress syndrome--20 years on.

Authors:  D J Shale
Journal:  Thorax       Date:  1987-09       Impact factor: 9.139

6.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

7.  In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function.

Authors:  B Lachmann; E P Eijking; K L So; D Gommers
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 8.  Review: artifical ventilation with positive end-expiratory pressure (PEEP). Historical background, terminology and patho-physiology.

Authors:  D B Stokke
Journal:  Eur J Intensive Care Med       Date:  1976-09

9.  Physiologic effects and side effects of prostaglandin E1 in the adult respiratory distress syndrome.

Authors:  J A Russell; J J Ronco; P M Dodek
Journal:  Chest       Date:  1990-03       Impact factor: 9.410

10.  The adult respiratory distress syndrome: first trials with surfactant replacement.

Authors:  P S Richman; R G Spragg; B Robertson; T A Merritt; T Curstedt
Journal:  Eur Respir J Suppl       Date:  1989-03
View more
  3 in total

1.  Exogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity.

Authors:  A van 't Veen; D Gommers; J W Mouton; J A Kluytmans; E J Krijt; B Lachmann
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Lipopolysaccharide "two-hit" induced refractory hypoxemia acute respiratory distress model in rats.

Authors:  Yumei Li; Hongchang Wei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

3.  In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome.

Authors:  Francesca Ricci; Fabrizio Salomone; Elke Kuypers; Daan Ophelders; Maria Nikiforou; Monique Willems; Tobias Krieger; Xabier Murgia; Matthias Hütten; Boris W Kramer; Federico Bianco
Journal:  Front Pediatr       Date:  2017-08-31       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.